Abivax S.A. SEC filings ABVX
Abivax S.A. has 105 filings in SEC EDGAR's recent list, going back to Dec 16, 2022. Its latest annual report, Form 20-F, was filed on Mar 23, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Sep 21, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| F-6EF | Filing | Sep 21, 2026 | — |
| 424B5 | Prospectus supplement | Jul 2, 2026 | — |
| FWP | Free writing prospectus | Jul 1, 2026 | — |
| FWP | Free writing prospectus | Jun 30, 2026 | — |
| 424B5 | Prospectus supplement | Jun 30, 2026 | — |
| 424B7 | Filing | May 7, 2026 | — |
| S-8 | Employee stock plan registration | Mar 23, 2026 | — |
| 424B5 | Prospectus supplement | Jul 24, 2025 | — |
| FWP | Free writing prospectus | Jul 24, 2025 | — |
| FWP | Free writing prospectus | Jul 23, 2025 | — |
| 424B5 | Prospectus supplement | Jul 23, 2025 | — |
| F-3ASR | Filing | Jul 23, 2025 | — |
| S-8 | Employee stock plan registration | Mar 24, 2025 | — |
| F-3 | Shelf registration (foreign issuer) | Nov 19, 2024 | — |
| 424B4 | Prospectus | Oct 23, 2023 | — |
| FWP | Free writing prospectus | Oct 20, 2023 | — |
| F-1/A | Filing | Oct 18, 2023 | — |
| F-1/A | Filing | Oct 16, 2023 | — |
| F-6 | Filing | Oct 3, 2023 | — |
| F-1 | Registration statement (foreign issuer) | Sep 29, 2023 | — |
Showing 20 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ABVX (Nasdaq), AAVXF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- France
- Headquarters
- Paris
- SEC filer status
- Accelerated filer, Emerging growth company
- SEC CIK
- 1956827
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.